Pharmafile Logo
Pharmafocus logo
Advanced Search

Sun Pharma

Showing 15 posts of 46 posts found.

Sun Pharma and Pharmazz enter license agreement for Tyvalzi in India

September 14, 2023
Sales and Marketing License Agreement, Neurology, Pharmazz, Sun Pharma, Tyvalzi, sovateltide

Sun Pharma has announced that one of its wholly owned subsidiaries has entered into a license agreement with Pharmazz in …

News
sun-pharma-759

Sun Pharma’s shares hit six-year low after further whistleblower allegations emerge

January 18, 2019
Medical Communications India, Sun Pharma, pharma

Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …

News
sunpharma

Sun Pharma’s New Jersey manufacturing overhaul puts 96 jobs at risk

November 26, 2018
Manufacturing and Production, Sales and Marketing Sun Pharma, manufacturing, pharma

Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to …

News
fda2outsideweb

Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer

May 23, 2018
Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer

Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …

News
sun_pharma

Sun Pharma receives approval for first biologic drug

March 22, 2018
Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical

The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …

News
sunpharma

Sun Pharma signs $55m manufacturing deal for investigational psoriasis drug

July 4, 2017
Manufacturing and Production Samsung BioLogics, Sun Pharma

India’s biggest pharma firm has signed a $55 million long-term manufacturing deal with Korea’s Samsung BioLogics for Tildrakizumab, an investigational …

News
sun_pharma

Sun Pharma rises again with FDA cholesterol drug approval

June 13, 2017
Manufacturing and Production Sun Pharma

Sun Pharma has had a rough time of late, the FDA has become more aggressive in its overseeing of manufacturing …

News
egypt_india_locator

Egypt and India ties in pharmaceuticals encouraged

April 11, 2017
Manufacturing and Production Egypt, India, Sun Pharma

India and Egypt have been tentatively trying to build economic links for the last few years, with a particular focus …

News
sun_pharma

FDA lifts block on Sun Pharma facility

March 14, 2017
Manufacturing and Production FDA, Sun Pharma

Sun Pharma has announced that the FDA informed it that the Import Alert in place upon its Mohali manufacturing facility …

News
egypt_india_locator

Sun Pharma inaugurates first Egypt production facility

February 23, 2017
Manufacturing and Production, Sales and Marketing Egypt, India, Ranbaxy, Sun Pharma

Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further …

News
index_ph001

Daiichi pulls out of India with closure of 170-strong R&D plant

January 11, 2017
Manufacturing and Production, Research and Development Daiichi Sankyo, Ranbaxy, Sun Pharma

Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …

News
sun_pharma

Blast at Sun Pharma factory kills two

January 4, 2017
Medical Communications, Research and Development Sun Pharma, factory, fire

A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …

News
sun_pharma

Sun Pharma to acquire Novartis’s drug for $175 million

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …

News
sun_pharma

Sun Pharma’s Halol plant’s leaky roof irks FDA

December 13, 2016
Manufacturing and Production FDA, Sun Pharma, inspection

The FDA’s two week inspection of Sun Pharmaceutical’s Halol plant produced a 14-page report, with some criticisms reserved for poorly …

News

Latest content

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023

EC approves Pfizer’s Litfulo for adolescents and adults with alopecia

September 19, 2023